Development of FGFR-based Bispecific ADCs

0 votes
asked Mar 2, 2022 in Cell Tracking by creativebiolabs22 (11,840 points)

Creative Biolabs is highly specialized in advanced antibody biochemistry and engineering. With more than a decade of exploration and expansion, our current research and service capacity covers the entire new drug discovery and development pipeline, ranging from early discovery, pre-clinical evaluations, cGMP manufacturing, to clinical trials.

Development of FGFR-based Bispecific ADCs

Please log in or register to answer this question.

Welcome to Bioimagingcore Q&A, where you can ask questions and receive answers from other members of the community.
...